news

Notice of Manufacturing and Marketing Approval Application for "ROH-101 (Ganciclovir Eye Drops Gel)," a Treatment for Cytomegalovirus Corneal Endotheliitis

Rohto's Recruitment and Work Style Real Report 2026: Aiming for Co-Growth of Individuals and the Company

Izumiotsu City x Rohto Pharmaceutical "Kodomo MY Mirai Ai Project": Three Eye Care Model Schools Selected

Rohto Group's proprietary ingredient, "Licorice Extract Powder (Lyconin®)," which contains the ingredient gliasperin B, has been approved as a functional food product for the first time in Japan.

Three new products from "Eu Yan Sang" will be released sequentially.

What determines whether you "like" a skincare product? A follow-up report: Exploring the relationship between changes in the feel of Gokujun and physiological indicators.

We have successfully constructed a next-generation artificial skin model attached to blood vessels that exhibits cellular diversity.

The impact of the digital age on "eye problems" and "eye aging," as well as its "correlation with skin," has also been revealed!

Announcement of the establishment of the "Integrated Science and Social Collaboration Course on Food Wellbeing" by Rohto Pharmaceutical Co., Ltd. and the University of Tokyo.

Rohto Children's Dream Fund has selected nine organizations as recipients for its third round of grants.

Launch of a "Humanoid Development Project" utilizing physical AI.

Announcement Regarding the Signing of a Naming Rights Sponsorship Agreement for Konoike Sports Park in Nara City

A survey was conducted in Obu City, Aichi Prefecture, regarding the current state of childhood myopia. While approximately 90% of parents intend to take preventative measures, only about 50% actually do so.

Rohto Eye Vision, Japan's only eye care product featuring a BTA formula specifically designed for children's eye inflammation, is now available.

New product launch: "V Rohto Dryguard Premium," an over-the-counter eye drop containing 1% high-molecular-weight chondroitin.

The long-loved "Rohto Pharmaceutical corporate commercial song" has been reborn with an arrangement by world-renowned pianist Hayato Sumino and has begun airing as a time signal in the city.

Kyoto Prefecture's Kizugawa City and Rohto Pharmaceutical Co., Ltd. have signed an agreement regarding the provision of temporary evacuation shelters during disasters.

A wearable medical device for managing symptoms of overactive bladder is set to be launched in the Chinese market.

Elucidation of the involvement of chondroitin sulfate in age-related inflammation of the cornea and conjunctiva

Certified as a "Certified Health & Productivity Management Outstanding Organization (White 500)" for the 9th time in 6 consecutive years

Regarding the issue of the old DRX brand website URL being redirected to a fraudulent site.

Initiatives to Ensure Safety in Cell Therapy

Notice of changes to packaging specifications due to environmental considerations

Publication of "Rohto Health White Paper 2025"

Please purchase from authorized Obagi retailers.

Initiatives to Ensure Safety in Cell Therapy

Setting new health and productivity management indicators for 2030

Report and Apology Regarding the Consumer Affairs Agency's Corrective Order

Revision of the "Multi-Stakeholder Policy"

Report and Apology Regarding the Consumer Affairs Agency's Corrective Order

Rohto Group formulates "Basic Policy on Customer Harassment"

Please be careful of suspicious investment solicitations related to our company.

Beware of counterfeit "Lush Rich" products

Please be aware of suspicious e-mails purporting to be from our company's employees and directors

Beware of counterfeit Obagi C25 Serum NEO products

Information about the pigments used in our sunscreen products

Notice of revision of precautions for use of eye drops (over-the-counter drugs) containing sodium sulfamethoxazole

Please be aware of suspicious e-mails purporting to be from our company's employees and directors

Regarding some reports about our company

On the occasion of our 125th anniversary, our corporate slogan and logo design have been renewed.

The winners of the 31st ROHTO AWARD research grants have been decided.

Recipients of the "Japanese Dermatological Association Dermatological Research Fund (Endowment by Rohto Pharmaceutical)" have been decided

We are pleased to announce the 19th recipient of Rohto Prize, a research fund specializing in Japanese Association of Geriatric Dermatology Research Fund skin.

Announcement of the public call for applications for the "Japanese Dermatological Association Dermatological Research Fund (Endowment by Rohto Pharmaceutical)"

The 16th recipients of the Rohto Women's Health Science Research Award have been announced

The recipients of the 30th ROHTO AWARD research grant have been decided.

Recipients of the "Japanese Dermatological Association Dermatological Research Fund (Endowment by Rohto Pharmaceutical)" have been decided

Announcement of the public call for applications for the "Japanese Dermatological Association Dermatological Research Fund (Endowment by Rohto Pharmaceutical)"

We are pleased to announce the 18th recipient of Rohto Prize, a research fund specializing in Japanese Association of Geriatric Dermatology Research Fund skin.

The 4th Rohto Regenerative medicine Forum was held

The 15th recipients of the Rohto Women's Health Science Research Award have been announced

The recipients of the 29th ROHTO AWARD research grant have been decided.

Recipients of the "Japanese Dermatological Association Dermatological Research Fund (Endowment by Rohto Pharmaceutical)" have been decided

Announcement of the public call for applications for the "Japanese Dermatological Association Dermatological Research Fund (Endowment by Rohto Pharmaceutical)"

We are pleased to announce the 17th recipient of Rohto Prize, a research fund specializing in Japanese Association of Geriatric Dermatology Research Fund skin.

The 3rd Rohto Regenerative medicine Forum was held

The 14th recipients of the Rohto Women's Health Science Research Award have been announced

The recipients of the 28th ROHTO AWARD research grant have been decided.

Recipients of the "Japanese Dermatological Association Dermatological Research Fund (Endowment by Rohto Pharmaceutical)" have been decided

Announcement of the public call for applications for the "Japanese Dermatological Association Dermatological Research Fund (Endowment by Rohto Pharmaceutical)"